filmovertrukne tabletter
Sponsors
Rigshospitalet, Gentofte Hospital, Frederiksberg Hospital, Bispebjerg Hospital, Aarhus University Hospital, Region Hovedstaden, Region Hovedstaden, Frederiksberg Hospital
Conditions
Bacterial infectionBipolar DisorderBlood poisoning in patients with renal failure treated with hemodialysisBreast cancerChronic obstructive pulmonary disease (COPD)Colorectal Cancer and Breast CancerDaytime urinary incontinence and overactive bladderGram-negative Bacteremia
Phase 1
Phase 2
The LIFE-MET Study:
Lifestyle intervention and Metformin in early puberty.
A randomized, placebo-controlled study on the effect of insulin sensitization and/or lifestyle intervention on pubertal progression.
RecruitingCTIS2024-511009-50-00
Start: 2024-08-27Target: 80Updated: 2025-11-19
NT-NOA - Novel Treatment of some men with Non-Obstructive Azoospermia
Et klinisk interventionsforsøg
Not yet recruitingCTIS2024-512996-11-00
Target: 16Updated: 2025-08-19
Hydroxychloroquine treatment for Recurrent Pregnancy Loss: a randomized double-blind placebo-controlled trial
RecruitingCTIS2024-515579-36-00
Start: 2017-04-12Target: 186Updated: 2025-12-02
Cannabidiol for treatment of non-affective psychosis and cannabis use
CompletedCTIS2024-517630-18-00
Start: 2024-10-08End: 2025-12-02Target: 64Updated: 2025-03-11
A Phase 2, open label, randomized study of neoadjuvant dostarlimab plus CAPEOX versus CAPEOX in participants with previously untreated T4N0 or Stage III MMRp/ MSS colon cancer
RecruitingCTIS2024-513441-36-00
Start: 2024-11-27Target: 170Updated: 2025-12-18
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of PPV-06 Active Immunotherapy in Patients with Inflammatory Knee Osteoarthritis (KOA).
Not yet recruitingCTIS2024-514388-24-00
Target: 204Updated: 2025-04-07
Phase 3
Perioperative treatment with Tranexamic Acid (TXA) in melanoma; prognostic and treatment related impact of the plasminogen-plasmin pathway
Active, not recruitingCTIS2022-502633-26-00
Start: 2023-08-25Target: 1204Updated: 2024-04-23
Efficacy of solifenacin, mirabegron and combination therapy in children with overactive bladder and daytime urinary incontinence (BeDry)
RecruitingCTIS2023-510187-13-00
Start: 2024-06-27Target: 236Updated: 2024-06-12
A Randomized, placebo-controlled, Phase III Study of (Neo)Adjuvant Atorvastatin Therapy in Patients with Early Breast Cancer
Active, not recruitingCTIS2024-515404-39-00
Start: 2021-01-14Target: 3360Updated: 2025-06-03
Phase 4
Reduced antithrombotic strategy for high bleeding risk patients with myocardial infarction treated with percutaneous coronary intervention - The Dan-DAPT trial
RecruitingCTIS2022-500125-32-00
Start: 2022-06-20Target: 2700Updated: 2025-11-18
COPD - Eosinophil-guided Reduction of Inhaled Corticosteroids (COPERNICOS)
CompletedCTIS2022-501035-16-01
Start: 2022-08-23End: 2025-12-16Target: 444Updated: 2024-06-04
Cluster and Registry trials Of the Working group of heart failure in Denmark - Are SPironolactone and Eplerenone Comparable Treatments? (CROWD-ASPECT)
RecruitingCTIS2022-502239-20-00
Start: 2023-01-01Target: 7200Updated: 2024-04-22
Lithium versus Lamotrigine in bipolar disorder, type II – a single blinded randomized controlled trial (the LiLa-Bipolar RCT)
RecruitingCTIS2023-509607-32-00
Start: 2024-04-29Target: 200Updated: 2025-03-10
PROPHYLACTIC ANTIBIOTIC TREATMENT IN END-STAGE KIDNEY DISEASE AND CENTRAL VENOUS CATHETER AS HEMODIALYSIS VASCULAR ACCESS
RecruitingCTIS2024-515001-26-00
Start: 2024-07-25Target: 800Updated: 2024-07-25
Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study
RecruitingCTIS2024-514900-16-00
Start: 2024-07-25Target: 380Updated: 2025-09-12
Endocrine, Cardiovascular, Pharmacological, and Physiological Aspects of Sex Hormone Therapy in Turner Syndrome - Study 2
RecruitingCTIS2024-518001-18-00
Start: 2021-11-29Target: 100Updated: 2024-10-08
Endocrine, Cardiovascular, Pharmacological, and Physiological Aspects of Sex Hormone Therapy in Turner Syndrome - Study 1
RecruitingCTIS2024-518557-42-00
Start: 2021-11-29Target: 50Updated: 2024-10-23
REINFORCE – Reducing infection-related readmissions following cystectomy. A multicentre randomised clinical trial testing superiority of individualised targeted antibiotic prophylaxis over empiric prophylaxis at ureteral stent removal to reduce infection-related readmissions following cystectomy.
RecruitingCTIS2024-514312-27-00
Start: 2025-01-07Target: 248Updated: 2024-12-10
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia:
A randomized, non-blinded, non-inferiority interventional study
RecruitingCTIS2024-519186-21-01
Start: 2025-01-30Target: 264Updated: 2025-11-17